European Meeting on HIV & Hepatitis 2021

We are deeply saddened to share that Dr. Charles Boucher, a member of the Organizing Committee of the European Meeting on HIV & Hepatitis 2021, has passed away after a courageous battle with cancer. Read our full memorial >

Founded nineteen years ago as the European HIV Resistance Workshop, the European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. Particular emphasis is put on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, and emerging viruses throughout Europe.

In the last decade, the meeting has been able to capture leading clinicians and researchers from different regions of Europe. As such, this meeting is the only European platform where HIV-treating physicians and clinical virologists get together on an annual basis to present their latest research results and discuss their clinical implications in detail. 

General Information 

Practical Information 

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.

The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

• Carlos Beltran, MD - Chilean AIDS Group, Chile
• Marina Bobkova, PhD - Ivanovsky Institute of Virology, Russia
• Rolf Kaiser, PhD - University of Cologne, Germany
• Leon Kostrikis, PhD - University of Cyprus, Cyprus
• Clive Loveday, PhD - ICVC Charitable Trust, Clinical Virology, United Kingdom
• Monique Nijhuis, PhD - University Medical Centre Utrecht, the Netherlands
• Milosz Parczewski, MD, PhD - Pomeranian Medical University, Poland
• Mario Poljak, MD, PhD - Institute for Microbiology and Immunology, Slovenia
• Gary Rubin, MD - University of Toronto, Canada
• Maria Santoro, MD - University of Rome "Tor Vergata", Italy
• Anders Sönnerborg, MD, PhD - Karolinska Institut, Sweden
• Janusz Stanczak, PhD - University of Warsaw, Poland
• Jens Verheyen, MD, PhD - Institute of Immunology and Genetics, Germany
• David van de Vijver, PharmD PhD - Erasmus University Rotterdam, the Netherlands
• Hauke Walter, MD - Medizinisches Labor Stendhal, Germany
• Maurizio Zazzi, PhD - University of Siena, Italy

The European Meeting on HIV & Hepatitis 2021 - Treatment Strategies & Antiviral Drug Resistance, Utrecht (Livestream), Netherlands, 26/05/2021-28/05/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 9 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Management of the COVID-19 Pandemic in Europe | Diagnostics

by Ravindra Gupta, MD, PhD from University of Cambridge, United Kingdom

Hepatitis C Resistance: Pro-Con Debate

• Pro - Standpoint | Francesca Ceccherini – Silberstein, PhD from University of Rome “Tor Vergata”, Italy
• Con- Standpoint | Jean-Michel Pawlotsky, MD, PhD from University of Paris-Est, France